Cancer IQ Blog

Are You Missing Patients Eligible for Testing?

Posted by Alexa McCarthy on Oct 4, 2017 2:52:37 PM

To identify a woman as a carrier only after she develops cancer is a failure of cancer prevention.” -Mary Claire King

Read More

Introducing a Faster Way to Order Tests in CancerIQ

Posted by Andrea Downing on Dec 5, 2016 6:44:57 PM
 At CancerIQ our mission is to empower providers to offer cancer genetics services at scale. To do that, we need to streamline the genetic test ordering process. The current workflow requires providers to find patients eligible for testing, obtain informed consent and then fill out a handful of different forms. It can be long and tedious with slow turnaround time.

Today we’re excited to announce a much-anticipated Electronic Test Ordering feature from CancerIQ that will make the test ordering process better for everyone.

Here’s how it works:

Read More

Topics: Genetic Counseling

Three Ways to Build More Referrals to Your Genetics Practice Without Burning Out

Posted by Alexa McCarthy on Sep 22, 2016 12:15:19 PM

Help your referring physicians identify patients at risk of HBOC

 Let's face it.  The majority of genetics practices are dealing with big problems when it comes to clinical workflow.

It really takes a village within a local healthcare system implement a plan to manage and navigate high-risk patients to the right experts.  In an ideal world all physicians would keep up with the NCCN guidelines, ask patients the right family history questions and identify all possible cases of hereditary cancer risk.

Unfortunately, that’s not the always the case.
Read More

Topics: Genetic Counseling

A Little More About Us...

In 2014, an interdisciplinary team of experts in clinical cancer genetics convened to solve a growing problem – patient access. With such a small group of trained practitioners with genetics expertise, there was a need to make the process more efficient, team-based, and scalable.

We aim to bring predictive analytics to the world of cancer care, starting with simple tools to predict, pre-empt, and prevent adverse outcomes in cancer.

Subscribe to Email Updates

Recent Posts

Posts by Topic